Description
🧪 Product Profile: AOD9604 5mg
Product Name: AOD9604
CAS Number: 221231-10-3
Formulation: 5mg lyophilized powder per vial
Purity: ≥99% (HPLC verified)

🔍 Key Characteristics
AOD9604 is a synthetic peptide derived from the C-terminal fragment of human growth hormone (HGH), specifically corresponding to amino acids 176-191. Unlike full-length HGH, it selectively targets fat metabolism pathways without affecting insulin-like growth factor (IGF-1) levels, making it a research tool for studying fat loss mechanisms.

⚙️ Mechanism of Action
Lipolysis Stimulation: Promotes the breakdown of stored fat by activating hormone-sensitive lipase, particularly in abdominal adipose tissue.
Lipogenesis Inhibition: Suppresses the conversion of non-fat nutrients into body fat, supporting metabolic balance in preclinical models.
Cartilage Regeneration: Demonstrates potential in preclinical studies for enhancing joint repair by modulating inflammation and promoting chondrocyte activity, especially when combined with peptides like BPC 157.
📊 Research Applications
Metabolic Studies: Investigations into obesity treatment, fat distribution, and metabolic syndrome.
Regenerative Medicine: Research on osteoarthritis and musculoskeletal tissue repair.
Anti-Aging Models: Exploration of secondary effects on skin elasticity and body composition in age-related decline studies.
💡 Product Features
Stability: Lyophilized form ensures long-term storage stability (-20°C to -80°C recommended).
Reconstitution: Requires sterile solvent (e.g., bacteriostatic water) for laboratory use.
Safety Profile: Preclinical data indicates minimal side effects, with no reported impact on blood glucose or cortisol levels.
⚠️ Important Notes
For Research Use Only: Not approved for human or veterinary clinical applications. Handling requires adherence to peptide research protocols, including proper PPE and biosafety measures.